ATE188738T1 - Aus t-lymphozyten gewonnener hämatopoietischer wachstumsfaktor und verfahren zu seiner verwendung - Google Patents

Aus t-lymphozyten gewonnener hämatopoietischer wachstumsfaktor und verfahren zu seiner verwendung

Info

Publication number
ATE188738T1
ATE188738T1 AT92916012T AT92916012T ATE188738T1 AT E188738 T1 ATE188738 T1 AT E188738T1 AT 92916012 T AT92916012 T AT 92916012T AT 92916012 T AT92916012 T AT 92916012T AT E188738 T1 ATE188738 T1 AT E188738T1
Authority
AT
Austria
Prior art keywords
csf
lymphocytes
granulocytes
macrophages
growth factor
Prior art date
Application number
AT92916012T
Other languages
English (en)
Inventor
Chandra Choudhury
Original Assignee
Chandra Choudhury
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chandra Choudhury filed Critical Chandra Choudhury
Application granted granted Critical
Publication of ATE188738T1 publication Critical patent/ATE188738T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Wood Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT92916012T 1991-07-12 1992-07-07 Aus t-lymphozyten gewonnener hämatopoietischer wachstumsfaktor und verfahren zu seiner verwendung ATE188738T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US72913591A 1991-07-12 1991-07-12
US74778491A 1991-08-19 1991-08-19
US78811591A 1991-11-01 1991-11-01
PCT/US1992/005707 WO1993000923A1 (en) 1991-07-12 1992-07-07 Hematopoietic growth factor derived from t lymphocytes and methods of use therefor

Publications (1)

Publication Number Publication Date
ATE188738T1 true ATE188738T1 (de) 2000-01-15

Family

ID=27419126

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92916012T ATE188738T1 (de) 1991-07-12 1992-07-07 Aus t-lymphozyten gewonnener hämatopoietischer wachstumsfaktor und verfahren zu seiner verwendung

Country Status (7)

Country Link
EP (1) EP0594764B1 (de)
JP (1) JPH06508995A (de)
AT (1) ATE188738T1 (de)
AU (1) AU673333B2 (de)
CA (1) CA2113190A1 (de)
DE (1) DE69230561T2 (de)
WO (1) WO1993000923A1 (de)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2633295B2 (ja) * 1987-06-12 1997-07-23 味の素株式会社 ヒトａｄｆをコードする遺伝子
WO1990014351A1 (en) * 1989-05-23 1990-11-29 Chandra Choudhury Hematopoietic growth factor derived form t lymphocytes and methods of use therefor

Also Published As

Publication number Publication date
EP0594764A1 (de) 1994-05-04
CA2113190A1 (en) 1993-01-21
DE69230561D1 (de) 2000-02-17
AU2347592A (en) 1993-02-11
JPH06508995A (ja) 1994-10-13
EP0594764A4 (de) 1994-11-23
DE69230561T2 (de) 2000-08-10
WO1993000923A1 (en) 1993-01-21
AU673333B2 (en) 1996-11-07
EP0594764B1 (de) 2000-01-12

Similar Documents

Publication Publication Date Title
Becker et al. Differential production of tumor necrosis factor, macrophage colony stimulating factor, and interleukin 1 by human alveolar macrophages
Broudy et al. Interleukin 1 stimulates human endothelial cells to produce granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor.
Le et al. Interleukin 2-dependent and interleukin 2-independent pathways of regulation of thymocyte function by interleukin 6.
Yokota et al. Isolation and characterization of lymphokine cDNA clones encoding mouse and human IgA-enhancing factor and eosinophil colony-stimulating factor activities: relationship to interleukin 5.
Kodama et al. Mc3T3‐G2/PA6 preadipoctyes support in vitro proliferation of hemopoietic stem cells through a mechanism different from that of interleukin 3
Lindemann et al. Granulocyte-macrophage colony-stimulating factor induces cytokine secretion by human polymorphonuclear leukocytes.
Hirayama et al. The flt3 ligand supports proliferation of lymphohematopoietic progenitors and early B-lymphoid progenitors
Ikebuchi et al. Synergistic factors for stem cell proliferation: further studies of the target stem cells and the mechanism of stimulation by interleukin-1, interleukin-6, and granulocyte colony-stimulating factor
McCarthy Jr et al. Inhibition of interleukin-1 by an interleukin-1 receptor antagonist prevents graft-versus-host disease
Wieser et al. Interleukin-4 induces secretion of CSF for granulocytes and CSF for macrophages by peripheral blood monocytes
Koopman et al. Evidence for the identification of lymphocyte activating factor as the adherent cell-derived mediator responsible for enhanced antibody synthesis by nude mouse spleen cells
Koike et al. Recombinant murine granulocyte‐macrophage (GM) colony‐stimulating factor supports formation of GM and multipotential blast cell colonies in culture: Comparison with the effects of interleukin‐3
Drexler et al. Cytokine response profiles of human myeloid factor-dependent leukemia cell lines
US4695542A (en) cDNA clones coding for polypeptides exhibiting multi-lineage cellular growth factor activity
Platzer et al. Human pluripotent hemopoietic colony stimulating factor: activities on human and murine cells
Nemunaitis et al. Human marrow stromal cells: response to interleukin-6 (IL-6) and control of IL-6 expression
Herrmann et al. Polypeptides controlling hematopoietic cell development and activation: I. In vitro results
Bressler et al. Inhibition of the growth of IL-3-dependent mast cells from murine bone marrow by recombinant granulocyte macrophage-colony-stimulating factor.
Enokihara et al. Interleukin 5 activity in sera from patients with eosinophilia
Peschel et al. Interleukin-4 induces a substance in bone marrow stromal cells that reversibly inhibits factor-dependent and factor-independent cell proliferation
Yoshida et al. Neutrophil chemotactic factors produced by a cell line from thyroid carcinoma
Agarwal et al. Long-term culture of chronic myelogenous leukemia marrow cells on stem cell factor-deficient stroma favors benign progenitors
Zupo et al. Production of granulocyte-macrophage colony-stimulating factor but not IL-3 by normal and neoplastic human B lymphocytes.
Watson Biology and biochemistry of T cell-derived lymphokines. I. The coordinate synthesis of interleukin 2 and colony-stimulating factors in a murine T cell lymphoma.
ATE188738T1 (de) Aus t-lymphozyten gewonnener hämatopoietischer wachstumsfaktor und verfahren zu seiner verwendung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee